The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
The Cardio IQ® Insulin Resistance Panel with Score test contains 1 test with 3 biomarkers.
Brief Description: The Cardio IQ® Insulin Resistance Panel with Score Test is a specialized panel of tests that is used to evaluate an individual's risk of insulin resistance, which is a precursor to type 2 diabetes. The results from these tests are combined to provide a score that represents the person’s risk level of insulin resistance.
Collection Method: Blood Draw
Specimen Type: Serum
Test Preparation: Overnight fasting is required.
This test may be ordered when an individual has risk factors for insulin resistance or type 2 diabetes such as obesity, a sedentary lifestyle, a family history of diabetes, or signs of metabolic syndrome. Additionally, it may be ordered if a person has abnormal lipid test results or other indicators of cardiovascular disease. This panel helps in early identification of insulin resistance which can be managed or reversed through lifestyle changes, thus preventing or delaying the onset of diabetes and other associated conditions.
The Cardio IQ® Insulin Resistance Panel with Score Test checks for Insulin Intact and C-Peptide, and provides an Insulin Resistance Score.
When this panel is ordered, it's usually part of a broader evaluation of metabolic health and cardiovascular risk. Here are some tests commonly ordered alongside it:
C-Reactive Protein (CRP), High-Sensitivity (hs-CRP):
These tests, when ordered alongside a Cardio IQ® Insulin Resistance Panel with Score, provide a comprehensive evaluation of an individual’s metabolic health and cardiovascular risk profile. They are crucial for diagnosing insulin resistance, assessing the risk of diabetes and cardiovascular disease, and guiding lifestyle and medical interventions to mitigate these risks. The specific combination of tests will depend on the individual’s clinical history, risk factors, and presenting symptoms.
Conditions that might warrant this test include metabolic syndrome, polycystic ovary syndrome (PCOS), suspected insulin resistance, and a family history of type 2 diabetes. Additionally, individuals with known cardiovascular disease or those with multiple cardiovascular risk factors may also benefit from this test.
Healthcare providers use the results of the Cardio IQ® Insulin Resistance Panel with Score Test to identify individuals at risk for insulin resistance and to initiate early interventions to manage or reverse this risk. The interventions might include dietary modifications, exercise, weight loss, and possibly medication to improve insulin sensitivity. Additionally, by identifying insulin resistance early, healthcare providers can monitor and manage other associated conditions such as cardiovascular disease, thereby improving the overall health and prognosis of the individual.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.